DelveInsight's Merkel Cell Carcinoma Market Insights report includes a comprehensive understanding of current treatment ...

A phase 1b trial is evaluating PH-762 for the treatment of cutaneous squamous cell carcinoma, melanoma and Merkel cell ...

Patients with advanced Merkel cell carcinoma had significant increases in survival rates following FDA approval of immune checkpoint inhibitors.

Negative surgical margins regardless of surgery type was associated with increased overall survival in patients with Merkel cell carcinoma.

The detection of metastases in Merkel cell carcinoma (MCC) requires additional testing, such as pancytokeratin (panCK) or CK20, with no guarantee of success. Recent findings have identified ...